James R. Campbell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
James R. Campbell has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
J. Edward Puzas
Department of Orthopedics, University of Rochester Medical Center, Rochester, New York, USA
1 shared publicationLeonore Novotny
Department of Orthopedics, University of Rochester Medical Center, Rochester, New York, USA
1 shared publicationMark E. Moss
1 shared publicationMary Paris
1 shared publicationPeggy Auinger
Department of Pediatrics, University of Rochester Medical Center, Rochester, New York, USA
1 shared publicationRandy N. Rosier
Department of Orthopedics, University of Rochester Medical Center, Rochester, New York, USA
1 shared publication
Latest Publications
- Open Access
- 1 July 2007
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 115 (7) , 1018-1022
The Association between Blood Lead Levels and Osteoporosis among Adults—Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Background: Osteoporosis is a reduction in bone mass sufficient to increase the risk of fracture. Lead exposure during childhood may be a risk factor for low bone mineral density (BMD). Basic-science research demonstrates that lead exposure is associated with a decrease in BMD in animals. However, human studies are limited. Objective: Our objective was to conduct a secondary analysis of a national database to explore the association between lead exposure and osteoporosis in adult humans. Methods: In this study we used data from the Third National Health and Nutrition Examination Survey (NHANES III). We analyzed subjects who were ≥ 50 years of age. A concurrent venous blood lead level defined lead exposure. The primary outcome variable was the BMD of the total hip. We conducted analyses on four groups: non-Hispanic white men, non-Hispanic white women, African-American men, and African-American women. We conducted bivariate analyses between covariates known to be associated with bone density (i.e., age, body mass index, calcium intake, ethanol/tobacco consumption, physical activity, socioeconomic status) and the total hip BMD. The significant covariates were introduced into analysis of covariance to determine the association between BMD and blood lead level tercile. Results: The adjusted mean total hip BMD among non-Hispanic white males with a blood lead level in the lowest tercile versus the highest tercile was 0.961 g/cm2 and 0.934 g/cm2, respectively (p < 0.05). We also found a similar association among white females, but the difference was marginally significant (0.05 < p < 0.10). Conclusions: We found a significant inverse association between lead exposure and BMD, but only among white subjects. However, because of the cross-sectional design of NHANES, we cannot make inferences about the temporal sequence of this association. With the large number of adults who had lead exposure in the past and the morbidity associated with osteoporosis, further inquiry is necessary on the possible casusal association between lead exposure and osteoporosis in humans.
- 1 July 2007
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 115 (7) , 1018-1022
Open AccessThe Association between Blood Lead Levels and Osteoporosis among Adults—Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Background: Osteoporosis is a reduction in bone mass sufficient to increase the risk of fracture. Lead exposure during childhood may be a risk factor for low bone mineral density (BMD). Basic-science research demonstrates that lead exposure is associated with a decrease in BMD in animals. However, human studies are limited. Objective: Our objective was to conduct a secondary analysis of a national database to explore the association between lead exposure and osteoporosis in adult humans. Methods: In this study we used data from the Third National Health and Nutrition Examination Survey (NHANES III). We analyzed subjects who were ≥ 50 years of age. A concurrent venous blood lead level defined lead exposure. The primary outcome variable was the BMD of the total hip. We conducted analyses on four groups: non-Hispanic white men, non-Hispanic white women, African-American men, and African-American women. We conducted bivariate analyses between covariates known to be associated with bone density (i.e., age, body mass index, calcium intake, ethanol/tobacco consumption, physical activity, socioeconomic status) and the total hip BMD. The significant covariates were introduced into analysis of covariance to determine the association between BMD and blood lead level tercile. Results: The adjusted mean total hip BMD among non-Hispanic white males with a blood lead level in the lowest tercile versus the highest tercile was 0.961 g/cm2 and 0.934 g/cm2, respectively (p < 0.05). We also found a similar association among white females, but the difference was marginally significant (0.05 < p < 0.10). Conclusions: We found a significant inverse association between lead exposure and BMD, but only among white subjects. However, because of the cross-sectional design of NHANES, we cannot make inferences about the temporal sequence of this association. With the large number of adults who had lead exposure in the past and the morbidity associated with osteoporosis, further inquiry is necessary on the possible casusal association between lead exposure and osteoporosis in humans.
- 1 August 2004
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 112 (11) , 1200-1203
The Association between Environmental Lead Exposure and Bone Density in Children
Osteoporosis is a decrease in bone mineral density (BMD) that predisposes individuals to fractures. Although an elderly affliction, a predisposition may develop during adolescence if a sufficient peak BMD is not achieved. Rat studies have found that lead ...
- 1 August 2004
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 112 (11) , 1200-1203
The Association between Environmental Lead Exposure and Bone Density in Children
Osteoporosis is a decrease in bone mineral density (BMD) that predisposes individuals to fractures. Although an elderly affliction, a predisposition may develop during adolescence if a sufficient peak BMD is not achieved. Rat studies have found that lead ...
- 23 January 2001
- Published by Wiley in The Journal of Trace Elements in Experimental Medicine
- Vol. 14 (1) , 69-72
Hair‐root lead to screen for lead toxicity
- 23 January 2001
- Published by Wiley in The Journal of Trace Elements in Experimental Medicine
- Vol. 14 (1) , 69-72
Hair‐root lead to screen for lead toxicity
- Open Access
- 1 November 2000
- Published by JSTOR in Environmental Health Perspectives
- Vol. 108 (11) , 1099
The Association between Caries and Childhood Lead Exposure
Epidemiologic studies suggest an association between lead exposure and caries. Our objective was to establish whether children with a higher lead exposure as toddlers had more caries at school age than children with a lower lead exposure. We used a retrospective ...
- 1 November 2000
- Published by JSTOR in Environmental Health Perspectives
- Vol. 108 (11) , 1099
Open AccessThe Association between Caries and Childhood Lead Exposure
Epidemiologic studies suggest an association between lead exposure and caries. Our objective was to establish whether children with a higher lead exposure as toddlers had more caries at school age than children with a lower lead exposure. We used a retrospective ...
- 1 June 1999
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 107 (6) , 437-440
Predicting the outcome of the CaNa2EDTA challenge test in children with moderately elevated blood lead levels.
The Centers for Disease Control and Prevention suggests the challenge test for children whose blood lead levels are 1.21-2.12 micromol/L (25-44 microg/dL). However, the challenge test is difficult to perform. By identifying children who are likely to have a negative challenge test, a medical provider can minimize the number of children undergoing this test. The goal of this study was to identify common tests that are likely to predict the outcome of the challenge test. It was conducted as a clinical descriptive study from a series of patients who underwent a CaNa2EDTA challenge test. Results from 178 challenge tests were eligible for analysis. The mean age of children undergoing the challenge test was 38.2 months, and the mean blood lead level was 1.83 micromol/L (38 microg/dL). Blood lead level, age, erythrocyte protoporphyrin level, and RATE (a measure of the rate of change of the blood lead level) were either not sensitive or not specific in predicting the outcome of a challenge test. However, based on a logistic regression model using blood lead level, age, and RATE, we determined criteria that would have identified all children who would have had a positive challenge test while excluding most children who would have had a negative challenge test. Based on this model, we recommend that the challenge test be conducted on children >=36 months of age who have a blood lead level between 1.45 and 1.64 micromol/L (30-34 microg/dL) and on children who have a blood lead level 1.69-2.12 micromol/L (35-44 microg/dL) regardless of age. This approach would have tested all children who subsequently would have had a positive challenge test while testing only 39% of children who would have had a negative challenge test.
- 1 June 1999
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 107 (6) , 437-440
Predicting the outcome of the CaNa2EDTA challenge test in children with moderately elevated blood lead levels.
The Centers for Disease Control and Prevention suggests the challenge test for children whose blood lead levels are 1.21-2.12 micromol/L (25-44 microg/dL). However, the challenge test is difficult to perform. By identifying children who are likely to have a negative challenge test, a medical provider can minimize the number of children undergoing this test. The goal of this study was to identify common tests that are likely to predict the outcome of the challenge test. It was conducted as a clinical descriptive study from a series of patients who underwent a CaNa2EDTA challenge test. Results from 178 challenge tests were eligible for analysis. The mean age of children undergoing the challenge test was 38.2 months, and the mean blood lead level was 1.83 micromol/L (38 microg/dL). Blood lead level, age, erythrocyte protoporphyrin level, and RATE (a measure of the rate of change of the blood lead level) were either not sensitive or not specific in predicting the outcome of a challenge test. However, based on a logistic regression model using blood lead level, age, and RATE, we determined criteria that would have identified all children who would have had a positive challenge test while excluding most children who would have had a negative challenge test. Based on this model, we recommend that the challenge test be conducted on children >=36 months of age who have a blood lead level between 1.45 and 1.64 micromol/L (30-34 microg/dL) and on children who have a blood lead level 1.69-2.12 micromol/L (35-44 microg/dL) regardless of age. This approach would have tested all children who subsequently would have had a positive challenge test while testing only 39% of children who would have had a negative challenge test.
- 1 June 1997
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 151 (6) , 636
Screening Strategies for Elevated Blood Lead Levels-Reply
- 1 June 1997
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 151 (6) , 636
Screening Strategies for Elevated Blood Lead Levels-Reply